Obinutuzumab in Refractory Phospholipase A2 Receptor-Associated Membranous Nephropathy With Severe CKD

Overview

Journal Kidney Int Rep

Publisher Elsevier

Specialty Nephrology

Date 2023 Apr 18

PMID 37069971

Authors

Sachin Naik

Shubham Shukla

Niranjan Av

Vinod Kumar

Aravind Sekar

Ritambhra Nada

Manish Rathi

Harbir Singh Kohli

Raja Ramachandran

Affiliations

Soon will be listed here.

Citing Articles

Obinutuzumab in membranous nephropathy: a potential game-changer in treatment.

Sessa C, Galeano D, Zanoli L, Delsante M, Rossi G, Morale W Drugs Context. 2025; 14.

PMID: 40017729 PMC: 11867167. DOI: 10.7573/dic.2024-9-1.

Obinutuzumab in Difficult to Treat Phospholipase A2 Receptor Positive Membranous Nephropathy: Our Experience at a Tertiary Care Center in North India.

Jha V, Panda S, Rai S, Srivastava A Indian J Nephrol. 2025; 35(1):91-96.

PMID: 39872260 PMC: 11763165. DOI: 10.25259/ijn_498_23.

Post-transplant glomerular diseases: update on pathophysiology, risk factors and management strategies.

Regalia A, Abinti M, Alfieri C, Campise M, Verdesca S, Zanoni F Clin Kidney J. 2024; 17(12):sfae320.

PMID: 39664990 PMC: 11630810. DOI: 10.1093/ckj/sfae320.

Therapeutic targets in membranous nephropathy: plasma cells and complement.

Tomas N Clin Kidney J. 2024; 17(9):sfae243.

PMID: 39239361 PMC: 11375337. DOI: 10.1093/ckj/sfae243.

Obinutuzumab as Initial or Second-Line Therapy in Patients With Primary Membranous Nephropathy.

Su X, Wu B, Tie X, Guo X, Feng R, Qiao X Kidney Int Rep. 2024; 9(8):2386-2398.

PMID: 39156138 PMC: 11328588. DOI: 10.1016/j.ekir.2024.05.004.

References

Goede V, Fischer K, Busch R, Engelke A, Eichhorst B, Wendtner C . Obinutuzumab plus chlorambucil in patients with CLL and coexisting conditions. N Engl J Med. 2014; 370(12):1101-10. DOI: 10.1056/NEJMoa1313984. View

Hanset N, Esteve E, Plaisier E, Johanet C, Michel P, Boffa J . Rituximab in Patients With Phospholipase A2 Receptor-Associated Membranous Nephropathy and Severe CKD. Kidney Int Rep. 2020; 5(3):331-338. PMC: 7056852. DOI: 10.1016/j.ekir.2019.12.006. View

Ramachandran R, Prabakaran R, Priya G, Nayak S, Kumar P, Kumar A . Immunosuppressive Therapy in Primary Membranous Nephropathy with Compromised Renal Function. Nephron. 2021; 146(2):138-145. DOI: 10.1159/000518609. View